img

Global Peptide-based Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Peptide-based Drug Market Insights, Forecast to 2034

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
Market Analysis and InsightsGlobal Peptide-based Drug Market
Global Peptide-based Drug market is expected to reach to US$ 37090 million in 2024, with a positive growth of %, compared with US$ 35410 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Peptide-based Drug industry is evaluated to reach US$ 62200 million in 2029. The CAGR will be 9.0% during 2024 to 2029.
The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.
Report Covers
This report presents an overview of global Peptide-based Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Peptide-based Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Segment by Type
Injection
Oral
Other

Segment by Application


Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Peptide-based Drug introduction, etc. Peptide-based Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Peptide-based Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-based Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide-based Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-based Drug Market Perspective (2018-2029)
2.2 Global Peptide-based Drug Growth Trends by Region
2.2.1 Peptide-based Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Peptide-based Drug Historic Market Size by Region (2018-2024)
2.2.3 Peptide-based Drug Forecasted Market Size by Region (2024-2029)
2.3 Peptide-based Drug Market Dynamics
2.3.1 Peptide-based Drug Industry Trends
2.3.2 Peptide-based Drug Market Drivers
2.3.3 Peptide-based Drug Market Challenges
2.3.4 Peptide-based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Peptide-based Drug by Players
3.1.1 Global Peptide-based Drug Revenue by Players (2018-2024)
3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2018-2024)
3.2 Global Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Peptide-based Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Peptide-based Drug Market Concentration Ratio
3.4.1 Global Peptide-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Drug Revenue in 2022
3.5 Global Key Players of Peptide-based Drug Head office and Area Served
3.6 Global Key Players of Peptide-based Drug, Product and Application
3.7 Global Key Players of Peptide-based Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-based Drug Breakdown Data by Type
4.1 Global Peptide-based Drug Historic Market Size by Type (2018-2024)
4.2 Global Peptide-based Drug Forecasted Market Size by Type (2024-2029)
5 Peptide-based Drug Breakdown Data by Application
5.1 Global Peptide-based Drug Historic Market Size by Application (2018-2024)
5.2 Global Peptide-based Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Peptide-based Drug Market Size (2018-2029)
6.2 North America Peptide-based Drug Market Size by Type
6.2.1 North America Peptide-based Drug Market Size by Type (2018-2024)
6.2.2 North America Peptide-based Drug Market Size by Type (2024-2029)
6.2.3 North America Peptide-based Drug Market Share by Type (2018-2029)
6.3 North America Peptide-based Drug Market Size by Application
6.3.1 North America Peptide-based Drug Market Size by Application (2018-2024)
6.3.2 North America Peptide-based Drug Market Size by Application (2024-2029)
6.3.3 North America Peptide-based Drug Market Share by Application (2018-2029)
6.4 North America Peptide-based Drug Market Size by Country
6.4.1 North America Peptide-based Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Peptide-based Drug Market Size by Country (2018-2024)
6.4.3 North America Peptide-based Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Peptide-based Drug Market Size (2018-2029)
7.2 Europe Peptide-based Drug Market Size by Type
7.2.1 Europe Peptide-based Drug Market Size by Type (2018-2024)
7.2.2 Europe Peptide-based Drug Market Size by Type (2024-2029)
7.2.3 Europe Peptide-based Drug Market Share by Type (2018-2029)
7.3 Europe Peptide-based Drug Market Size by Application
7.3.1 Europe Peptide-based Drug Market Size by Application (2018-2024)
7.3.2 Europe Peptide-based Drug Market Size by Application (2024-2029)
7.3.3 Europe Peptide-based Drug Market Share by Application (2018-2029)
7.4 Europe Peptide-based Drug Market Size by Country
7.4.1 Europe Peptide-based Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Peptide-based Drug Market Size by Country (2018-2024)
7.4.3 Europe Peptide-based Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Peptide-based Drug Market Size (2018-2029)
8.2 China Peptide-based Drug Market Size by Type
8.2.1 China Peptide-based Drug Market Size by Type (2018-2024)
8.2.2 China Peptide-based Drug Market Size by Type (2024-2029)
8.2.3 China Peptide-based Drug Market Share by Type (2018-2029)
8.3 China Peptide-based Drug Market Size by Application
8.3.1 China Peptide-based Drug Market Size by Application (2018-2024)
8.3.2 China Peptide-based Drug Market Size by Application (2024-2029)
8.3.3 China Peptide-based Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Peptide-based Drug Market Size (2018-2029)
9.2 Asia Peptide-based Drug Market Size by Type
9.2.1 Asia Peptide-based Drug Market Size by Type (2018-2024)
9.2.2 Asia Peptide-based Drug Market Size by Type (2024-2029)
9.2.3 Asia Peptide-based Drug Market Share by Type (2018-2029)
9.3 Asia Peptide-based Drug Market Size by Application
9.3.1 Asia Peptide-based Drug Market Size by Application (2018-2024)
9.3.2 Asia Peptide-based Drug Market Size by Application (2024-2029)
9.3.3 Asia Peptide-based Drug Market Share by Application (2018-2029)
9.4 Asia Peptide-based Drug Market Size by Region
9.4.1 Asia Peptide-based Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Peptide-based Drug Market Size by Region (2018-2024)
9.4.3 Asia Peptide-based Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Peptide-based Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Peptide-based Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Peptide-based Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Peptide-based Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide-based Drug Introduction
11.1.4 Sanofi Revenue in Peptide-based Drug Business (2018-2024)
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Peptide-based Drug Introduction
11.2.4 Teva Revenue in Peptide-based Drug Business (2018-2024)
11.2.5 Teva Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide-based Drug Introduction
11.3.4 Novo Nordisk Revenue in Peptide-based Drug Business (2018-2024)
11.3.5 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide-based Drug Introduction
11.4.4 Takeda Revenue in Peptide-based Drug Business (2018-2024)
11.4.5 Takeda Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide-based Drug Introduction
11.5.4 Eli Lilly Revenue in Peptide-based Drug Business (2018-2024)
11.5.5 Eli Lilly Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide-based Drug Introduction
11.6.4 AstraZeneca Revenue in Peptide-based Drug Business (2018-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide-based Drug Introduction
11.7.4 Novartis Revenue in Peptide-based Drug Business (2018-2024)
11.7.5 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide-based Drug Introduction
11.8.4 AbbVie Revenue in Peptide-based Drug Business (2018-2024)
11.8.5 AbbVie Recent Developments
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide-based Drug Introduction
11.9.4 Ipsen Revenue in Peptide-based Drug Business (2018-2024)
11.9.5 Ipsen Recent Developments
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide-based Drug Introduction
11.10.4 Ferring Revenue in Peptide-based Drug Business (2018-2024)
11.10.5 Ferring Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Peptide-based Drug Introduction
11.11.4 Merck Revenue in Peptide-based Drug Business (2018-2024)
11.11.5 Merck Recent Developments
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide-based Drug Introduction
11.12.4 The Medicines Revenue in Peptide-based Drug Business (2018-2024)
11.12.5 The Medicines Recent Developments
11.13 J & J
11.13.1 J & J Company Details
11.13.2 J & J Business Overview
11.13.3 J & J Peptide-based Drug Introduction
11.13.4 J & J Revenue in Peptide-based Drug Business (2018-2024)
11.13.5 J & J Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peptide-based Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide-based Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Peptide-based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Peptide-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Peptide-based Drug Market Share by Region (2018-2024)
Table 9. Global Peptide-based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Peptide-based Drug Market Share by Region (2024-2029)
Table 11. Peptide-based Drug Market Trends
Table 12. Peptide-based Drug Market Drivers
Table 13. Peptide-based Drug Market Challenges
Table 14. Peptide-based Drug Market Restraints
Table 15. Global Peptide-based Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Peptide-based Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Peptide-based Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2022)
Table 18. Global Peptide-based Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Peptide-based Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Peptide-based Drug, Headquarters and Area Served
Table 21. Global Key Players of Peptide-based Drug, Product and Application
Table 22. Global Key Players of Peptide-based Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Peptide-based Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Peptide-based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Peptide-based Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Peptide-based Drug Revenue Share by Application (2018-2024)
Table 30. Global Peptide-based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Peptide-based Drug Revenue Share by Application (2024-2029)
Table 32. North America Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Peptide-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Peptide-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Peptide-based Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Peptide-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Peptide-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Peptide-based Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Peptide-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Peptide-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Peptide-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Peptide-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Peptide-based Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Peptide-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Peptide-based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Peptide-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Peptide-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Peptide-based Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 64. Sanofi Company Details
Table 65. Sanofi Business Overview
Table 66. Sanofi Peptide-based Drug Product
Table 67. Sanofi Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 68. Sanofi Recent Developments
Table 69. Teva Company Details
Table 70. Teva Business Overview
Table 71. Teva Peptide-based Drug Product
Table 72. Teva Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 73. Teva Recent Developments
Table 74. Novo Nordisk Company Details
Table 75. Novo Nordisk Business Overview
Table 76. Novo Nordisk Peptide-based Drug Product
Table 77. Novo Nordisk Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 78. Novo Nordisk Recent Developments
Table 79. Takeda Company Details
Table 80. Takeda Business Overview
Table 81. Takeda Peptide-based Drug Product
Table 82. Takeda Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 83. Takeda Recent Developments
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Peptide-based Drug Product
Table 87. Eli Lilly Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 88. Eli Lilly Recent Developments
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Peptide-based Drug Product
Table 92. AstraZeneca Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 93. AstraZeneca Recent Developments
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Peptide-based Drug Product
Table 97. Novartis Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 98. Novartis Recent Developments
Table 99. AbbVie Company Details
Table 100. AbbVie Business Overview
Table 101. AbbVie Peptide-based Drug Product
Table 102. AbbVie Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 103. AbbVie Recent Developments
Table 104. Ipsen Company Details
Table 105. Ipsen Business Overview
Table 106. Ipsen Peptide-based Drug Product
Table 107. Ipsen Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 108. Ipsen Recent Developments
Table 109. Ferring Company Details
Table 110. Ferring Business Overview
Table 111. Ferring Peptide-based Drug Product
Table 112. Ferring Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 113. Ferring Recent Developments
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Peptide-based Drug Product
Table 117. Merck Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 118. Merck Recent Developments
Table 119. The Medicines Company Details
Table 120. The Medicines Business Overview
Table 121. The Medicines Peptide-based Drug Product
Table 122. The Medicines Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 123. The Medicines Recent Developments
Table 124. J & J Company Details
Table 125. J & J Business Overview
Table 126. J & J Peptide-based Drug Product
Table 127. J & J Revenue in Peptide-based Drug Business (2018-2024) & (US$ Million)
Table 128. J & J Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide-based Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Peptide-based Drug Market Share by Type: 2022 VS 2029
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Other Features
Figure 6. Global Peptide-based Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Peptide-based Drug Market Share by Application: 2022 VS 2029
Figure 8. Cancer Case Studies
Figure 9. Metabolic Disorders Case Studies
Figure 10. Central Nervous System Case Studies
Figure 11. Other Case Studies
Figure 12. Peptide-based Drug Report Years Considered
Figure 13. Global Peptide-based Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Peptide-based Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Peptide-based Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Peptide-based Drug Market Share by Players in 2022
Figure 17. Global Top Peptide-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Peptide-based Drug Revenue in 2022
Figure 19. North America Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Peptide-based Drug Market Share by Type (2018-2029)
Figure 21. North America Peptide-based Drug Market Share by Application (2018-2029)
Figure 22. North America Peptide-based Drug Market Share by Country (2018-2029)
Figure 23. United States Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Peptide-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Peptide-based Drug Market Share by Type (2018-2029)
Figure 27. Europe Peptide-based Drug Market Share by Application (2018-2029)
Figure 28. Europe Peptide-based Drug Market Share by Country (2018-2029)
Figure 29. Germany Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Peptide-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Peptide-based Drug Market Share by Type (2018-2029)
Figure 37. China Peptide-based Drug Market Share by Application (2018-2029)
Figure 38. Asia Peptide-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Peptide-based Drug Market Share by Type (2018-2029)
Figure 40. Asia Peptide-based Drug Market Share by Application (2018-2029)
Figure 41. Asia Peptide-based Drug Market Share by Region (2018-2029)
Figure 42. Japan Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Peptide-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Peptide-based Drug Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Peptide-based Drug Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Peptide-based Drug Market Share by Country (2018-2029)
Figure 52. Brazil Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Peptide-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Sanofi Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 59. Teva Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 60. Novo Nordisk Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 61. Takeda Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 62. Eli Lilly Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 63. AstraZeneca Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 64. Novartis Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 65. AbbVie Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 66. Ipsen Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 67. Ferring Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 68. Merck Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 69. The Medicines Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 70. J & J Revenue Growth Rate in Peptide-based Drug Business (2018-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries